Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | PNP | P00491 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8834668 | 0.74 | ALDH1A1 (0.41) | LMNACYP1A2CYP2D6CHRM2SMN1; SMN2 | |
| SCHEMBL1404275 | 0.70 | CHRM2 (0.46) | CHRM2KMT2AKDM4EMAPTMEN1 | |
| SCHEMBL9387184 | 0.69 | GAA (0.40) | CYP1A2CYP2D6PNPKMT2AKDM4E | |
| SCHEMBL28895241 | 0.67 | ALDH1A1 (0.36) | LMNACYP1A2CYP2D6CHRM2SMN1; SMN2 | |
| SCHEMBL12069748 | 0.66 | POLB (0.39) | LMNACYP1A2PNPSMN1; SMN2KMT2A | |
| SCHEMBL11004553 | 0.66 | BACE1 (0.51) | LMNACYP1A2CYP2D6PNPSMN1; SMN2 | |
| SCHEMBL7364036 | 0.64 | MEN1 (0.38) | CHRM2KMT2AKDM4EMAPTMEN1 | |
| SCHEMBL15366561 | 0.64 | CHRM2 (0.36) | CHRM2KMT2AKDM4EMAPTMEN1 | |
| SCHEMBL14713173 | 0.64 | HSD17B10 (0.40) | LMNACYP1A2CYP2D6PNPSMN1; SMN2 | |
| SCHEMBL11629972 | 0.63 | HSPA5 (0.52) | LMNACYP2D6SMN1; SMN2KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230286964-A1 | Liquid Bio-based Benzoxazine Resin Systems with Improved Processability and High Performance | DREXEL UNIVERISTY (US) | 2023-09-14 | — | — | US | claimed |
| WO-2022035579-A2 | LIQUID BIO-BASED BENZOXAZINE RESIN SYSTEMS WITH IMPROVED PROCESSABILITY AND HIGH PERFORMANCE | PALMESE GIUSEPPE RAFAELLO (US) | 2022-02-17 | — | — | WO | claimed |
| US-20230286964-A1 | Liquid Bio-based Benzoxazine Resin Systems with Improved Processability and High Performance | DREXEL UNIVERISTY (US) | 2023-09-14 | — | — | US | disclosed |
| WO-2022035579-A2 | LIQUID BIO-BASED BENZOXAZINE RESIN SYSTEMS WITH IMPROVED PROCESSABILITY AND HIGH PERFORMANCE | PALMESE GIUSEPPE RAFAELLO (US) | 2022-02-17 | — | — | WO | disclosed |
| US-10221280-B2 | Acrylated or methacrylated urethane oligomer without isocyanate | ARKEMA FRANCE (FR) | 2019-03-05 | — | — | US | disclosed |
| US-20160122473-A1 | ACRYLATED OR METHACRYLATED URETHANE OLIGOMER WITHOUT ISOCYANATE | ARKEMA FRANCE (FR) | 2016-05-05 | — | — | US | disclosed |
| EP-0699712-B1 | Vulcanized polyolefinic plastoelastomer composition and a process for its preparation | ENICHEM SPA (IT) | 1997-11-19 | — | — | EP | disclosed |
| US-5523356-A | DYNAMICALLY VULCANIZED THERMOPLASTIC ELASTOMERS CONTAINING HOMO-OR COPOLYMERS OF PROPYLENE, ISOBUTYLENE, ETHYLENE, BUTADIENE, AND OTHER ALPHA-OLEFINS AND DIENES | ENICHEM ELASTOMERI S.R.L. (IT) | 1996-06-04 | — | — | US | disclosed |
| EP-0699712-A1 | Vulcanized polyolefinic plastoelastomer composition and a process for its preparation | ENICHEM ELASTOMERI S.r.l. (IT) | 1996-03-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230286964-A1 | Liquid Bio-based Benzoxazine Resin Systems with Improved Processability and High Performance | TBXAS1, BRIX1, BTD | LMNA 814/4885CYP1A2 347/4885CYP2D6 1315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.